Related Experiment Video

Updated: Sep 17, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

384

Decoding Diabetic Ketoacidosis: What a Pediatrician Needs to Know

Nicole Cyrus, Ian Cacho-Santana, Heather Fagan

    Pediatric Annals
    |July 3, 2025
    PubMed

    Insights

    Diabetic ketoacidosis (DKA) can present unusually, even with tachypnea as the first sign in new-onset type 1 diabetes. Pediatricians need awareness of diverse DKA symptoms for timely diagnosis and treatment.

    Area of Science:

    • Pediatrics
    • Endocrinology
    • Critical Care Medicine

    Background:

    • Diabetic ketoacidosis (DKA) is a serious complication of diabetes mellitus.
    • New-onset type 1 diabetes mellitus frequently presents as DKA in children.
    • General pediatric providers may lack awareness of DKA's varied presentations.

    Purpose of the Study:

    • To enhance general pediatricians' recognition of DKA risk factors and variable symptoms.
    • To improve the diagnostic timeline and critical treatment initiation for DKA.
    • To highlight tachypnea as a potential initial symptom of DKA.

    Main Methods:

    • Case report presentation of a patient with tachypnea as the initial symptom of DKA.
    • Review of DKA background, presentation, and differential diagnosis.
    • Discussion of essential management steps for pediatricians.

    Main Results:

    • A case illustrating tachypnea as the sole initial symptom of DKA and new-onset type 1 diabetes.
    • Emphasis on the variability of DKA presentations beyond typical symptoms.
    • Identification of key management principles for pediatricians.

    Conclusions:

    • Increased pediatrician awareness of DKA's diverse presentations is crucial.
    • Prompt recognition and management of DKA can improve patient outcomes.
    • Tachypnea should be considered in the differential diagnosis of DKA in pediatric patients.

    More Related Videos

    Improving IV Insulin Administration in a Community Hospital12:08

    Improving IV Insulin Administration in a Community Hospital

    Published on: June 11, 2012

    19.0K
    Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice10:31

    Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

    Published on: May 2, 2025

    285

    Related Concept Videos

    Diabetes: Symptoms, Diagnosis, and Complications01:15

    Diabetes: Symptoms, Diagnosis, and Complications

    For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
    702
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    3.0K
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
    1.2K
    Diagnosing Acidosis and Alkalosis01:24

    Diagnosing Acidosis and Alkalosis

    Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
    First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
    Next, the PCO2  and...
    543
    Diabetes Mellitus: Overview and Type I Subtype01:22

    Diabetes Mellitus: Overview and Type I Subtype

    Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
    Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
    3.3K
    Hypoglycemia and Glucagon01:15

    Hypoglycemia and Glucagon

    Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
    349